Babak Parviz, Vice President at Amazon, leads a discussion on synthetic biology, the multi-disciplinary field that applies engineering principles to redesign biological systems for new purposes. The panel focuses on bio-medical technologies that hold great promise for curing diseases and even counteracting human aging.
Starting with the premise that any substance can be poisonous depending on the dose, Josh Gilder, founding partner of Reach Global Strategies argues that government policies related to synthetic pesticides, GMOs, and organic farming is reducing years of massive gains in agricultural production and is leading to declining crop yields and malnutrition.
Matt McIlwain, Managing Director of Madrona Venture Group, moderates a panel on exciting innovations in biotech that are offering new ways to both eliminate diseases and extend life. Panelists include Dr. Steve Meyer, Director of Discovery Institute’s Center for Science and Culture, and Dr. Jim Tour, Professor of Chemistry at Rice University.
Discovery Institute Senior Fellow Jay Richards interviews Matt Scholz, CEO Of OISON Biotechnologies, on new approaches to killing disease and living longer.
